Atlas Trials

Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases

Clinical trial NCT05911230 · RECRUITING

Trial details

NCT number
NCT05911230
Sponsor
University Hospital, Basel, Switzerland
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioblastoma (GBM)
Start date
2022-11-24
Primary completion
2025-11-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.